Rationale, design, and implementation of aggressive risk factor management in the stenting and aggressive medical management for prevention of recurrent stroke in intracranial stenosis (SAMMPRIS) trial

Circulation: Cardiovascular Quality and Outcomes

Volumn 5, Issue 5, 2012, Pages

  Turan, Tanya N ^a   Lynn, Michael J ^b   Nizam, Azhar ^b   Lane, Bethany ^b   Egan, Brent M ^a   Le, Ngoc Anh ^b,c   Lopes Virella, Maria F ^a   Hermayer, Kathie L ^a   Benavente, Oscar ^d   White, Carole L ^e   Virgil Brown, W ^b,c   Caskey, Michelle F ^a   Steiner, Meghan R ^a   Vilardo, Nicole ^f   Stuffebean, Andrew ^a   Derdeyn, Colin P ^g   Fiorella, David ^h   Janis, Scott ⁱ   Chimowitz, Marc I ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b EMORY UNIVERSITY   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f DARTMOUTH MEDICAL SCHOOL   (United States)

^g WASHINGTON UNIVERSITY   (United States)

^h STONY BROOK UNIVERSITY   (United States)

ⁱ NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Atherosclerosis; Cerebrovascular circulation; Lifestyle; Risk factors; Stroke

Indexed keywords

ATENOLOL; CANDESARTAN; CHLORTALIDONE; CLONIDINE; FELODIPINE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDRALAZINE; LISINOPRIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; SPIRONOLACTONE; TRIACYLGLYCEROL;

ARTICLE; CEREBROVASCULAR ACCIDENT; EXERCISE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTRACRANIAL STENOSIS; LIFESTYLE MODIFICATION; OCCLUSIVE CEREBROVASCULAR DISEASE; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK MANAGEMENT; SMOKING CESSATION; STENTING AND AGGRESSIVE MEDICAL MANAGEMENT FOR PREVENTION OF RECURRENT STROKE IN INTRACRANIAL STENOSIS TRIAL; SYSTOLIC BLOOD PRESSURE; WEIGHT CONTROL;

ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; COMBINED MODALITY THERAPY; CONSTRICTION, PATHOLOGIC; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; RECURRENCE; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; STENTS; STROKE; TREATMENT OUTCOME;

EID: 84868654745     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.112.966911     Document Type: Article

References (50)

1. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-1516. (Pubitemid 46588415)
2. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Hal-perin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch Y Y, Sacco RL, Schwamm LH, Wassertheil-Smoller S, Turan TN, Wentworth D; American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42:227-276.
3. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445-453.
4. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421-8.
5. EVA-3S Investigators. Endarterectomy vs. Angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial. Cerebrovasc Dis. 2004;18:62-65.
6. Sheffet AJ, Roubin G, Howard G, Howard V, Moore W, Meschia JF, Hob-son RW, Brott TG. Design of the Carotid Revascularization Endarterec-tomy vs. Stenting Trial (CREST). Int J Stroke. 2010;5:40-46.
7. Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF; CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11-23.
8. Mas JL, Trinquart L, Leys D, Albucher JF, Rousseau H, Viguier A, Bossavy JP, Denis B, Piquet P, Garnier P, Viader F, Touze E, Julia P, Gir-oud M, Krause D, Hosseini H, Becquemin JP, Hinzelin G, Houdart E, He-non H, Neau JP, Bracard S, Onnient Y, Padovani R, Chatellier G; EVA-3S investigators. Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol. 2008;7:885-892.
9. Diener HC, Sacco R, Yusuf S; Steering Committee; PRoFESS Study Group. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fxed-dose combination of extended-release dipyridamole plus ASA with clopido-grel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). Cerebrovasc Dis. 2007;23:368-380. (Pubitemid 46742325)
10. PROGRESS Collaborative Group. Randomised trial of perindopril-based blood-pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041.
11. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA; Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-559.
12. Benavente OR, White CL, Pearce L, Pergola P, Roldan A, Benavente MF, Coffey C, McClure LA, Szychowski JM, Conwit R, Heberling PA, Howard G, Bazan C, Vidal-Pergola G, Talbert R, Hart RG; SPS3 Investigators. The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke. 2011;6:164-175.
13. Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: A large worldwide burden but a relatively neglected frontier. Stroke. 2008;39:2396-2399.
14. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology. 2003;22:106-117.
15. Chaturvedi S, Turan TN, Lynn MJ, Kasner SE, Romano J, Cotsonis G, Frankel M, Chimowitz MI; WASID Study Group. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007;69:2063-2068. (Pubitemid 350175708)
16. Chimowitz MI, Lynn MJ, Turan TN, Fiorella D, Lane BF, Janis S, Derdeyn CP; SAMMPRIS Investigators. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis. 2011;20:357-368.
17. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL, Jr., Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993-1003.
18. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title LM, Eisenberg D, Shurzinske L, McCormick LS. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Ator-vastatin versus Revascularization Treatment Investigators. N Engl J Med. 1999;341:70-76. (Pubitemid 29314237)
19. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., Jones DW, Materson BJ, Oparil S, Wright JT, Jr., Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
20. Turan TN, Lynn MJ, Cotsonis G, Chaturvedi S, Chimowitz MI. Risk factors associated with recurrent ischemic stroke in patients with symptomatic intracranial arterial stenosis. Int J Stroke. 2006;1:S99. Abstract
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the Second Report Of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment Of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 269(23):3015-3023
22. Expert Panel on Detection Evaluation Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486-2497.
23. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Jr., Clark LT, Hunning-hake DB, Pasternak RC, Smith SC, Jr., Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-239. (Pubitemid 38924592)
24. American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care. 2006;29(Suppl 1):S4-42.
25. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T; American Heart Association/American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affrms the value of this guideline. Circulation. 2006;113:e409-e449.
26. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, Heyman RB, Jaén CR, Lando HA, Mecklenburg RE, Mullen PD, Nett LM, Robinson L, Stitzer ML, Tommasello AC, Wewers ME, Kottke TE. Treating tobacco use and dependence. Quick reference guide for clinicians. Rockville, MD: US Department of Health and Human Services. Public Health Service. October 2000.
27. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH; American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898-918.
28. Pearson TA, Peters TD. The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient. Am J Cardiol. 1997;80(8 B):45H-52H. (Pubitemid 27515243)
29. Marcelino JJ, Feingold KR. Inadequate treatment with HMG-CoA reduc-tase inhibitors by health care providers. Am J Med. 1996;100:605-610. (Pubitemid 26243669)
30. Muls E, de Bbacker G, de Bacquer D, Brohet M, Heller F. Lipi-watch, a belgian/luxembourg survey on achievement of european atherosclerosis society lipid goals. Clin Drug Investig. 2000;19:219-229 (Pubitemid 30166915)
31. Lafranchise EF, Widener WG, Franklin BA, Salmon RD, Leight on RF, English CD, Gordon NF. Need for and clinical effectiveness of a neurologist supervised, nurse case managed stroke risk reduction program. Stroke. 2000;32:367-c. Abstract
32. Gordon NF, English CD, Contractor AS, Salmon RD, Leighton RF, Franklin BA, Haskell WL. Effectiveness of three models for comprehensive cardiovascular disease risk reduction. Am J Cardiol. 2002;89:1263-1268. (Pubitemid 34606886)
33. Gordon NF, Salmon RD, Franklin BA, Sperling LS, Hall L, Leighton RF, Haskell WL. Effectiveness of therapeutic lifestyle changes in patients with hypertension, hyperlipidemia, and/or hyperglycemia. Am J Cardiol. 2004;94:1558-1561. (Pubitemid 40268463)
34. Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005;45:89-118. (Pubitemid 40261799)
35. Ray KK, Cannon CP, McCabe CH, Cairns R, Tonkin AM, Sacks FM, Jackson G, Braunwald E; PROVE IT-TIMI 22 Investigators. Early and late Benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol. 2005;46:1405-1410. (Pubitemid 41446173)
36. Brown WV, Bays HE, Hassman DR, McKenney J, Chitra R, Hutchinson H, Miller E; Rosuvastatin Study Group. Efficacy and safety of rosuvas-tatin compared with pravastatin and simvastatin in patients with hyper-cholesterolemia: A randomized, double-blind, 52-week trial. Am Heart J. 2002;144:1036-1043. (Pubitemid 36026917)
37. * Trial). Am J Cardiol. 2003;92:152-160.
38. Davidson MH. Rosuvastatin safety: lessons from the FDA review and post-approval surveillance. Expert Opin Drug Saf. 2004;3:547-557. (Pubitemid 39530208)
39. Gröschel K, Ernemann U, Schulz JB, Nägele T, Terborg C, Kastrup A. Statin therapy at carotid angioplasty and stent placement: effect on procedure-related stroke, myocardial infarction, and death. Radiology. 2006;240:145-151. (Pubitemid 43902604)
40. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
41. Lindsey CC, Graham MR, Johnston TP, Kiroff CG, Freshley A. A clinical comparison of calculated versus direct measurement of low-density lipo-protein cholesterol level. Pharmacotherapy. 2004;24:167-172. (Pubitemid 38209435)
42. O'Brien E, Petrie J, Littler W, de Swiet M, Padfield PL, Altmanu DG, Bland M, Coats A, Atkins N. The british hypertension society protocol for the evaluation of blood pressure measuring devices. J Hypertens. 1993;11:S43-S62.
43. Calfas KJ, Long BJ, Sallis JF, Wooten WJ, Pratt M, Patrick K. A controlled trial of physician counseling to promote the adoption of physical activity. Prev Med. 1996;25:225-233. (Pubitemid 126335233)
44. Maron DJ, Boden WE, O'Rourke RA, Hartigan PM, Calfas KJ, Mancini GB, Spertus JA, Dada M, Kostuk WJ, Knudtson M, Harris CL, Sedlis SP, Zoble RG, Title LM, Gosselin G, Nawaz S, Gau GT, Blaus-tein AS, Bates ER, Shaw LJ, Berman DS, Chaitman BR, Weintraub WS, Teo KK; COURAGE Trial Research Group. Intensive multifacto-rial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revasculariza-tion and Aggressive Drug Evaluation) trial. J Am Coll Cardiol. 2010;55:1348-1358.
45. Egan BM, Laken MA, Shaun Wagner C, Mack SS, Seymour-Edwards K, Dodson J, Zhao Y, Lackland DT. Impacting population cardiovascular health through a community-based practice network: update on an ASH-supported collaborative. J Clin Hypertens (Greenwich). 2011;13:543-550.
46. Townsend RR, Shulkin DJ, Bernard D. Improved outpatient hypertension control with disease management guidelines. Am J Hypertens. 1999;12:88.
47. Turan TN, Nizram A, Lynn MJ, Derdeyn CP, Fiorella D, Lane BF, Megan Steiner, L S Janis, Marc I Chimowitz. the SAMMPRIS Investigators. Impact of an aggressive medical management protocol on early risk factor measures in the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial. Stroke. 2012;43:A141. Abstract.
48. Thomas RJ, King M, Lui K, Oldridge N, Piña IL, Spertus J; American Association of Cardiovascular and Pulmonary Rehabilitation/American College of Cardiology/American Heart Association Cardiac Rehabilitation/Secondary Prevention Performance Measures Writing Committee. AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services. Circulation. 2007;116:1611-1642.
49. Eijkenaar F. Pay for performance in health care: An international overview of initiatives. Med Care Res Rev. 2012;69:251-276.
50. Nahab F, Kingston C, Frankel MR, Dion JE, Cawley CM, Mitchell B, Hammonds LP, Ayala L, Tong FC. Early Aggressive Medical Management for Patients with Symptomatic Intracranial Stenosis. J Stroke Cerebrovasc Dis. Published ahead of print, July 25, 2011.